Jeffrey C. Hanselman,Rai Ajit K. Srivastava,Roger S. Newton
申请号：
US15125401
公开号：
US20170209402A1
申请日:
2015.03.20
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention provides methods of using carboxy-cyclopropyl undecanol compounds and pharmaceutically acceptable salts thereof to treat liver disease and other medical disorders associated with elevated lipid levels in the liver. Exemplary carboxy-cyclopropyl undecanol compounds described herein include 1,11-bis-(1-carboxy-cyclopropyl)-undecan-6-ol and pharmaceutically acceptable salts thereof.
